Ticker: CTKB

Company Overview Cytek Biosciences, Inc. (NASDAQ: CTKB) is a leading cell analysis solutions company specializing in flow cytometry and imaging technologies. The company aims to enhance biomedical research and clinical applications through advanced tools like their Full Spectrum Profiling technol...

Cytek Biosciences, Inc. (NASDAQ: CTKB) - Quarterly Analysis (Q1 2025) Income Statement Overview: Total Revenue: $41.5 million (a decrease of 8% compared to Q1 2024 revenue of $44.9 million) Product Revenue: $28.1 million (down 18% from $34.1 million in Q1 2024) Service Revenue: $13.3 million (up...